Cardiovascular risk and androgen deprivation therapy for prostate cancer: systematic review and meta-analysis of randomised controlled trials and observational studies (METADTCR) - Archive ouverte HAL Access content directly
Conference Papers Year : 2015

Cardiovascular risk and androgen deprivation therapy for prostate cancer: systematic review and meta-analysis of randomised controlled trials and observational studies (METADTCR)

Abstract

no abstract
Not file

Dates and versions

hal-01198645 , version 1 (14-09-2015)

Identifiers

Cite

L. -M. Scailteux, Florian Naudet, Q. Alimi, S. Vincendeau, E Oger. Cardiovascular risk and androgen deprivation therapy for prostate cancer: systematic review and meta-analysis of randomised controlled trials and observational studies (METADTCR). 12th Conference of the European Association for Clinical Pharmacology and Therapeutics, 2015, Madrid, Spain. pp.e3, ⟨10.1016/j.clinthera.2015.05.017⟩. ⟨hal-01198645⟩
62 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More